Tag: Pharmaceuticals
US: California AG sues Abbvie for illegal kickbacks
Pharmaceutical company Abbvie had its shares drop about 3% last week after California’s insurance commissioner Dave Jones sued the company, alleging Abbvie has been...
US: Pay-for-delay lawsuit settled for US$270m
Endo International Plc, Teva Pharmaceuticals and Teikoku Seijaku have agreed to pay a cumulative US$270.8 million to resolve class action lawsuits alleging Endo paid...
Innovation and the Firm: A New Synthesis
Posted by Social Science Research Network
Innovation and the Firm: A New Synthesis
By Peter Lee (University of California)
Abstract: Recent scholarship highlights the...
EU: Commission objects to Teva-Cephalon “pay-for-delay”
The European Commission has informed pharmaceutical company Teva of its preliminary view that an agreement concluded with Cephalon was in breach of EU antitrust...
US: West Virginia joins multi-state price fixing law suit
West Virginia Attorney General Patrick Morrisey joined a multistate lawsuit alleging antitrust violations involving an antibiotic, an oral diabetes medication and six generic drug...
US: Ranbaxy pay-for-delay trial starts
As complex as reverse-payment antitrust lawsuits can be, the one being litigated against generic drug maker Ranbaxy over its settlement with Cephalon can be...
South Africa: Pfizer denies over-charging for cancer drugs
US drugmaker Pfizer has denied allegations it overcharged for cancer medicines in South Africa following an investigation launched on Tuesday by the country’s competition...
Sharing, Samples, and Generics: An Antitrust Framework
Posted by Social Science Research Network
Sharing, Samples, and Generics: An Antitrust Framework
By Michael A. Carrier (Rutgers Law School)
Abstract: Rising drug prices are in...
US: EpiPen maker may have overcharged taxpayers by $1.27 billion
Mylan Pharmaceuticals, the maker of EpiPens for allergy sufferers, may have overcharged taxpayers as much as $1.27 billion by misclassifying their life-saving devices under...
NDRC’s Enforcement In 2016
By Susan Ning, Kate Peng, Sibo Gao and Ting Gong -
Since the enactment of the Anti-monopoly Law (“AML”) in 2008, China’s AML enforcement has gained...
